The House of Representatives Votes to Cap Insulin Prices at $35, Again

by | Apr 3, 2022 | Politics & Corruption, Human Rights & Justice, Quick Facts

Photo by David Moruzzi

The House of Representatives Votes to Cap Insulin Prices at $35, Again

by | Apr 3, 2022 | Politics & Corruption, Human Rights & Justice, Quick Facts

Photo by David Moruzzi
Republicans who voted against protecting diabetics from inflated insulin prices are clearly in the camp of corporate profits over human lives. This dramatically points to the dire necessity of finally instituting universal healthcare.

As reported by NPR and other outlets, the House of Representatives voted Thursday to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare. The vote was 232-193, with 12 Republican members joining their Democratic colleagues to pass the measure.

Two facts are staring back at us with this vote. First, the majority of Republicans voted against the measure. And even more glaring, this is not the first time this cap has been passed by the House.

The first attempt to cap insulin prices was passed in November of 2021 as part of the Bill Back Better bill.

Build back better was notable for being a massive investment in the “human” side of rebuilding the infrastructure of the U.S. It is also notable for being sabotaged by two corrupt members of the Democratic party, Joe Manchin and Kyrsten Simena.

These two Senator are well noted for their close ties with the pharma industry. Joe Manchin’s daughter, Heather Bresch, is the former CEO of Mylan Pharma—infamous for her price gouging and profiteering of life saving EpiPens.

Kyrsten Simena ran on a platform of lowering drug prices but then accepted mind-blowing amounts of money from the pharma lobby and now votes their way on all issues.

The pharma lobby, operating to protect an industry that is fully addicted to price gouging and profiteering, does not care which side of the aisle it dumps cash into. Their only interest is in being able to maintain their stranglehold on American healthcare wallets. Pharma companies already routinely charge 10 times or more in the U.S. than in other countries.

Build Back Better contained far more that scared Big Pharma than a cap on insulin. It would have restored Medicare’s right to negotiate drug prices directly and this could not be allowed from their viewpoint.

Republicans who voted against protecting diabetics from insulin price gouging are clearly in the camp of corporate profits over human lives. This amplifies the dire necessity for finally instituting universal healthcare.

But the position of Republicans is that such a system is “communist” and “cost prohibitive.” Both arguments are hollow. The first has been being used since Truman attempted to establish it in 1947 and the latter is just false. Projected costs for universal healthcare are about $3 trillion per year. But we spent 30 percent more than that on for-profit healthcare in 2020 alone.

It is a good thing that Members of Congress that have their constituents in mind rather than donors are acting in the pubic interest. That’s the way things are supposed to work. Now we need to shove this through the Senate. Failing this, the White House may need to find a legal precedent to force this price reduction through executive action. Either way, the price gouging of at least insulin has to end. Once it does, action on other inflated drug prices can follow. And this is precisely what Big Pharma fears.

Let’s let those fears become a reality.

1 Comment

  1. Bobbi

    Great article!!!!

    Reply

Submit a Comment

Your email address will not be published.

Related Articles

Sep 24 2022

DeSantis Sued Again for His Martha’s Vineyard Stunt

A Florida state senator has filed a lawsuit against Governor Ron DeSantis for his abuse of Florida state funds for his Martha’s Vineyard scheme.
Sep 22 2022

Time to Use 14th Amendment Against Lawmakers Who Betrayed Their Oaths on January 6

Citizens for Responsibility and Ethics in Washington argues there some current and future members of Congress should be disqualified from holding office under Section 3...
Sep 22 2022

New York’s Lawsuit Against Donald Trump — A Tax Lawyer Explains What’s at Stake

While the New York Attorney General’s massive lawsuit against Donald Trump, his children and companies is a civil suit, it marks a beginning and an acceleration...
Sep 21 2022

How Privatization and Corruption Magnified Puerto Rico’s Vulnerability to Hurricanes

Still recovering from the 2017 disaster of Hurricane Maria, which killed 3000 Americans in Puerto Rico, the islands have been blacked again out by much smaller...
Sep 21 2022

Martha’s Vineyard Migrants Sue DeSantis

The migrants flown to Martha’s Vineyard by DeSantis had actually been pursuing legal immigration channels when they were conned into leaving their shelter. They...
woman raise signage
Sep 20 2022

A New Survey Shows the Top Issues Motivating American Voters

A 19th/Survey Monkey Survey finds the economy is a bigger deal for Republicans and preserving democracy is bigger for Democrats as a motivating factor in this year’s...
Sep 18 2022

The Republican Governors Using Cruelty as a Campaign Strategy

The idea that cruelty can serve as a political tool should give us all pause. Our humanity as a nation is at stake when politicians seek support from those who view...
Sep 17 2022

What Is Behind the Diminishing Trust in Government Institutions?

Our government institutions are the glue that actually holds our society together and keep things rolling. What happens when that glue stops sticking?
Sep 15 2022

The Sacklers and Purdue Pharma Were Not Alone in Creating and Profiting From the Opioid Crisis

The Sacklers became the public face of the opioid crisis despite not being the only players. They were the first to hypermarket opioids and then led the pack in blaming...
U.S. Rep. Josh Gottheimer (D-N.J.) speaks during an April 6, 2022 press conference at the U.S. Capitol. Gottheimer is among the nearly 100 members of U.S. Congress whose ownership or trading of financial assets overlapped with their committee work. (Photo: Kevin Dietsch/Getty Images)
Sep 14 2022

Conflict of Interest: Members of Congress Trading Stocks

We need more action on legislation that would ban Congressional stock trading. And fewer members of Congress in violation of the rules already on the books.
Subscribe for Updates!

Subscribe for Updates!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Pin It on Pinterest

Share This